Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shock
- PMID: 24883321
- PMCID: PMC4022165
- DOI: 10.1155/2014/712742
Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shock
Abstract
Objectives: To investigate cortisol levels in brain dysfunction in patients with severe sepsis and septic shock.
Methods: In 128 septic and sedated patients, we studied brain dysfunction including delirium and coma by the evaluation of Richmond Agitation Sedation Scale (RASS), the Confusion Method Assessment in the ICU (CAM-ICU) after sedation withdrawal and the measurement of serum S100B biomarker of brain injury. Serum cortisol and S100B were measured within 12 hours after ICU admission and daily over the next four days.
Results: Brain dysfunction was observed in 50% (64/128) before but in 84% (107/128) of patients after sedation withdrawal, and was more common in the patients older than 57 years (P = 0.009). Both cortisol (P = 0.007) and S100B levels (P = 0.028) were higher in patients with than patients without brain dysfunction. Cortisol levels were associated with ICU mortality (hazard ratio = 1.17, P = 0.024). Multivariate logistic regression showed that cortisol (odds ratio (OR): 2.34, 95% CI (2.01, 3.22), P = 0.02) and the combination effect of cortisol with age (OR: 1.004, 95% CI (1.002, 1.93), P = 0.038) but not S100B were associated with brain dysfunction.
Conclusions: Cortisol was an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shock.
Figures
Similar articles
-
Endothelial Activation and Blood-Brain Barrier Injury as Risk Factors for Delirium in Critically Ill Patients.Crit Care Med. 2016 Sep;44(9):e809-17. doi: 10.1097/CCM.0000000000001739. Crit Care Med. 2016. PMID: 27088157 Free PMC article.
-
Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock.Crit Care Med. 2006 Jul;34(7):1967-74. doi: 10.1097/01.CCM.0000217218.51381.49. Crit Care Med. 2006. PMID: 16607230
-
Elevated serum S-100β in patients with septic shock is associated with delirium.Acta Anaesthesiol Scand. 2019 Jan;63(1):69-73. doi: 10.1111/aas.13228. Epub 2018 Aug 5. Acta Anaesthesiol Scand. 2019. PMID: 30079511
-
A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients.J Intensive Care Med. 2019 Aug;34(8):674-681. doi: 10.1177/0885066617710643. Epub 2017 Jun 1. J Intensive Care Med. 2019. PMID: 28569132 Clinical Trial.
-
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.Crit Care Med. 2008 Jan;36(1):296-327. doi: 10.1097/01.CCM.0000298158.12101.41. Crit Care Med. 2008. PMID: 18158437
Cited by
-
Diagnostic and prognostic value of serum S100B in sepsis-associated encephalopathy: A systematic review and meta-analysis.Front Immunol. 2023 Jan 27;14:1102126. doi: 10.3389/fimmu.2023.1102126. eCollection 2023. Front Immunol. 2023. PMID: 36776893 Free PMC article.
-
Factors contributing to sepsis-associated encephalopathy: a comprehensive systematic review and meta-analysis.Front Med (Lausanne). 2024 May 21;11:1379019. doi: 10.3389/fmed.2024.1379019. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38835794 Free PMC article.
-
The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy.Sci Rep. 2020 May 7;10(1):7718. doi: 10.1038/s41598-020-64200-3. Sci Rep. 2020. PMID: 32382007 Free PMC article.
-
Unveiling neurogenic biomarkers for the differentiation between sepsis patients with or without encephalopathy: an updated meta-analysis.Syst Rev. 2025 Feb 8;14(1):38. doi: 10.1186/s13643-025-02784-5. Syst Rev. 2025. PMID: 39923061 Free PMC article.
-
Abnormal Sleep, Circadian Rhythm Disruption, and Delirium in the ICU: Are They Related?Front Neurol. 2020 Sep 18;11:549908. doi: 10.3389/fneur.2020.549908. eCollection 2020. Front Neurol. 2020. PMID: 33071941 Free PMC article. Review.
References
-
- Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. The New England Journal of Medicine. 1995;332(20):1351–1362. - PubMed
-
- Webster JI, Sternberg EM. Role of the hypothalamic-pituitary-adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products. Journal of Endocrinology. 2004;181(2):207–221. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous